News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Genetown
Synageva BioPharma to Present at the Leerink Swann and Company Global Healthcare Conference 2013
February 7, 2013
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced its presentation at the upcoming Leerink Swann Global Healthcare Conference 2013.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
CDC
Republicans Ratchet Up Pressure as Monarez Levels Damning Allegations Against Kennedy
September 17, 2025
·
4 min read
·
Heather McKenzie
IN PARTNERSHIP WITH Pii, A JABIL COMPANY
Webinar: Bridging Formulation & Device | Integrated Supply Chain Strategies for US Pharma Manufacturing
September 17, 2025
·
1 min read
·
BioSpace Insights
Obesity
EASD 2025: Orforglipron in Focus, the Case for Cardiovascular Benefits, More
September 15, 2025
·
6 min read
·
Tristan Manalac
Government
Second MAHA Report Emphasizes Chronic Disease, Tilts at Vaccine Reform
September 9, 2025
·
3 min read
·
Heather McKenzie
